Keyphrases
Cancer Patients
100%
Personalized Medicine
100%
Patient-derived Xenograft
100%
Xenograft
100%
Surgeons
100%
Biliary Tract Cancer
100%
Clinical High Risk
40%
Surgical Resection
40%
Patient Tumor
40%
Immunodeficient Mice
40%
Cancer Xenograft
40%
Recapitulation
40%
PDX Model
40%
Mate-pair Sequencing
40%
Tumor Morphology
40%
Biliary Tract Tumors
40%
Patient Outcomes
20%
Malignancy
20%
Tumor
20%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
20%
Cancer Treatment
20%
Radiologic
20%
Histologic
20%
Engraftment
20%
Patient-derived
20%
Pathologist
20%
Engraft
20%
Tumor Protein p53 (TP53)
20%
Low Incidence
20%
Highly Aggressive
20%
Successful Development
20%
Survival Outcomes
20%
Histological Analysis
20%
Poor Survival
20%
Genomic Analysis
20%
Tumor Characteristics
20%
Malignant Tissue
20%
Recurrence-free Survival
20%
Biliary Cancer
20%
Hepatobiliary
20%
SMAD4
20%
Large Series
20%
Neuregulin-1 (NRG1)
20%
Biliary Tract Carcinoma
20%
Subsequent Therapy
20%
Recurrence Risk
20%
Patient with Tumor
20%
Oncological Outcomes
20%
Resection Specimen
20%
Lay Summary
20%
Tetraploid Genome
20%
Medicine and Dentistry
Personalized Medicine
100%
Xenograft
100%
Surgeon
100%
Biliary Tract Cancer
100%
Neoplasm
71%
Tumor Xenograft
28%
Biopsy Technique
28%
Biliary Tract Tumor
28%
Cancer Therapy
14%
Cancer
14%
Clinical Study
14%
Engraftment
14%
Pathologist
14%
Recurrence Risk
14%
Cholangiocarcinoma
14%
Recurrence Free Survival
14%
Bile Duct Cancer
14%
Biliary Duct Cancer
14%
Tetraploidy
14%
Cyclin Dependent Kinase Inhibitor 2A
14%
Biliary Tract
14%